A new wave of cell and gene therapies are revolutionizing how we treat and potentially cure certain diseases. While new therapies are gaining steam and starting to change patients’ lives, reimbursement and access challenges remain. Experts on this panel will discuss today’s challenges and what the future holds for potentially lifesaving cell and gene therapies.

Launching a new drug is far from straightforward, and it’s becoming increasingly difficult to craft and execute a successful launch strategy. How are companies navigating the challenges and approaching launches differently? A panel of industry experts will dive into that question and share the latest winning strategies